New DNA test could speed up personalized TB treatment
NCT ID NCT05007795
First seen May 09, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This study tests whether a new DNA sequencing method using sputum can quickly identify which TB drugs will work for patients with drug-resistant tuberculosis. Current tests are slow and miss some resistance, leading to poor outcomes. The trial will compare the new approach to standard testing in 280 adults with rifampicin-resistant TB to see if it helps doctors start effective treatment faster.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS, MULTIDRUG-RESISTANT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Cape Town
Cape Town, Western Cape, South Africa
Conditions
Explore the condition pages connected to this study.